Tenaya Therapeutics Appoints New Chief Financial Officer

Tenaya Therapeutics, Inc. has announced the appointment of Eric Hyllengren as its new Chief Financial Officer, effective July 13, 2026. Mr. Hyllengren will also assume the roles of Principal Financial Officer and Principal Accounting Officer for the company. This move signifies a change in the financial leadership of the biotechnology firm.